Towards a Four-Component GMMA-Based Vaccine against <i>Shigella</i>
Shigellosis remains a major public health problem around the world; it is one of the leading causes of diarrhoeal disease in low- and middle-income countries, particularly in young children. The increasing reports of <i>Shigella</i> cases associated with anti-microbial resistance are an...
Main Authors: | Francesca Micoli, Usman N. Nakakana, Francesco Berlanda Scorza |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/2/328 |
Similar Items
-
Exploring the Role of GMMA Components in the Immunogenicity of a 4-Valent Vaccine against <i>Shigella</i>
by: Francesca Mancini, et al.
Published: (2023-02-01) -
GMMA Is a Versatile Platform to Design Effective Multivalent Combination Vaccines
by: Francesca Micoli, et al.
Published: (2020-09-01) -
Development of a Monocyte Activation Test as an Alternative to the Rabbit Pyrogen Test for Mono- and Multi-Component <i>Shigella</i> GMMA-Based Vaccines
by: Danielle Carson, et al.
Published: (2021-06-01) -
GMMA-Based Vaccines: The Known and The Unknown
by: Francesca Mancini, et al.
Published: (2021-08-01) -
Comparison of Shigella GMMA and glycoconjugate four-component formulations in animals
by: Roberta Di Benedetto, et al.
Published: (2023-11-01)